Achieve Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements (Tables)

Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2012

Summary of assets and liabilities measured at fair value on recurring basis


December 31, 2012	Level 1		Level 2		Level 3		Total
Assets
Cash	$	2,440	$	—	$	—	$	2,440
Money market securities		15,949		—		—		15,949
Corporate bonds and commercial paper		—		57,308		—	$	57,308
Total assets	$	18,389	$	57,308	$	—	$	75,697
Liabilities
Warrants	$	—	$	—	$	3,422	$	3,422

December 31, 2011	Level 1		Level 2		Level 3		Total
Assets
Cash	$	5,725	$	—	$	—	$	5,725
Money market securities		21,163		—		—		21,163
Corporate bonds and commercial paper		—		38,416		—		38,416
Total assets	$	26,888	$	38,416	$	—	$	65,304
Liabilities
Warrants	$	—	$	—	$	7,881	$	7,881

Summary of marketable securities


December 31, 2012	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Cash	$	2,440	$	—	$	—		$	2,440
Money market securities		15,635		—		—			15,635
Corporate bonds and commercial paper		—		—		—			—
Total cash and cash equivalents	$	18,075	$	—	$	—		$	18,075
Money market securities		314		—		—			314
Total restricted cash	$	314	$	—	$	—		$	314
U.S. government securities		—		—		—			—
U.S. agency securities		—		—		—			—
Corporate bonds and commercial paper		57,312		4		(8	)		57,308
Total short-term investments	$	57,312	$	4	$	(8	)	$	57,308


December 31, 2011	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Cash	$	5,725	$	—	$	—		$	5,725
Money market securities		20,786		—		—			20,786
Corporate bonds and commercial paper		2,006		—		—			2,006
Total cash and cash equivalents	$	28,517	$	—	$	—		$	28,517
Money market securities		377		—		—			377
Total restricted cash	$	377	$	—	$	—		$	377
Corporate bonds and commercial paper		36,414		7		(11	)		36,410
Total short-term investments	$	36,414	$	7	$	(11	)	$	36,410

Summary of changes in fair value of Level 3 financial liabilities


	Liability at December 31, 2011		Gain on warrants		Liability at December 31, 2012
Warrant liability	$	7,881	$	4,459	$	3,422

- Definition

Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.

+ References + Details

- Definition

Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.

+ References + Details